Table 1.

Clinical Demographics

	Entire Cohort (n=35)	Training (n=20)	Validation (n=5)	Testing (n=10)	P-Value
Age (years)	65 ± 9.3	66 ± 9.3	64 ± 10.0	65 ± 10.0	0.941
Male N (%)	23 (66%)	12 (60%)	3 (60%)	8 (80%)	0.530
Persistent AF N (%)	35 (100%)	20 (100%)	5 (100%)	10 (100%)	1.000
Prior AF Ablation N (%)	16 (46%)	10 (50%)	3 (60%)	3 (30%)	0.460
AF History (days)	96 [31–133]	100 [38–130]	47 [28–734]	120 [15–830]	0.544
Hypertension N (%)	22 (63%)	13 (65%)	3 (60%)	6 (60%)	0.955
LA diameter (mm)	46 ± 8.1	45 ± 9.6	51 ± 5.3	47 ± 4.7	0.494
LV ejection fraction (%)	55 ± 10	56 ± 10	48 ± 8.8	57 ± 9.1	0.235
CHADSVASc score	2 ± 1.3	2 ± 1.4	2 ± 2.1	2 ± 1.2	0.999
Coronary disease N (%)	6 (17%)	4 (20%)	1 (20%)	1 (10%)	0.778

^*Values are mean ± SD, median [quartiles], or N (%)